Abeona Therapeutics (ABEO)

P/S ratio as of November 2024 (TTM): N/A

According to Abeona Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.44. At the end of 2024 the company had a P/S ratio of N/A.

P/S ratio history for Abeona Therapeutics from 2001 to 2024

PS ratio at the end of each year

Year	P/S ratio	Change
2024	N/A	-100%
2023	35.5	-5.22%
2022	37.4	127.16%
2021	16.5	6.47%
2020	15.5
2019	N/A	-100%
2018	882	-0.39%
2017	886	306.31%
2016	218	106.08%
2015	106	42.09%
2014	74.4	2263.44%
2013	3.15	133.71%
2012	1.35	-92.54%
2011	18.1	-81.67%
2010	98.6	-19.94%
2009	123	108.26%
2008	59.1	176.25%
2007	21.4
2005	15.1	-84.92%
2004	100	85.25%
2003	54.0	213.91%
2002	17.2	-92.68%
2001	235

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Taro Pharmaceutical TARO	2.64	N/A	🇮🇱 Israel
Merck MRK	4.04	N/A	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Abeona Therapeutics (ABEO)

P/S ratio as of November 2024 (TTM): N/A